Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chitra Hosing

Showing results (141-150 of 234) with videos related to

Pageof 24
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myelomaGaurav C Parikh, Ali Imran Amjad, Rima M Saliba, et al.
Frontiers in Immunology|November 9, 2018
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood TransplantationKai Cao, David Marin, Takuye Sekine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplantMuzaffar H Qazilbash, Rima M Saliba, Bilal Ahmed, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansionDongxia Xing, Alan G Ramsay, John G Gribben, et al.
Cancer|January 20, 2021
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndromeBetül Oran, Rima M Saliba, Rohtesh S Mehta, et al.
American Journal of Hematology|July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplantSameh Gaballa, Rima M Saliba, Samer Srour, et al.
Bone Marrow Transplantation|March 26, 2021
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationPaul Koller, Rima M Saliba, Celina Ledesma, et al.
Blood|August 6, 2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host diseaseSimrit Parmar, Marcos Del Lima, Yizhou Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
Pageof 24

Showing results (141-150 of 234) with videos related to

Sort By:
Pageof 24
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myelomaGaurav C Parikh, Ali Imran Amjad, Rima M Saliba, et al.
Frontiers in Immunology|November 9, 2018
Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood TransplantationKai Cao, David Marin, Takuye Sekine, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 25, 2010
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myelomaYvonne A Efebera, Sofia R Qureshi, Suzanne M Cole, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 19, 2007
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplantMuzaffar H Qazilbash, Rima M Saliba, Bilal Ahmed, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 29, 2010
Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansionDongxia Xing, Alan G Ramsay, John G Gribben, et al.
Cancer|January 20, 2021
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndromeBetül Oran, Rima M Saliba, Rohtesh S Mehta, et al.
American Journal of Hematology|July 16, 2016
Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplantSameh Gaballa, Rima M Saliba, Samer Srour, et al.
Bone Marrow Transplantation|March 26, 2021
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationPaul Koller, Rima M Saliba, Celina Ledesma, et al.
Blood|August 6, 2009
Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host diseaseSimrit Parmar, Marcos Del Lima, Yizhou Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 17, 2017
Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil RecoveryRohtesh S Mehta, Rima M Saliba, Kai Cao, et al.
Pageof 24